Financhill
Buy
82

G Quote, Financials, Valuation and Earnings

Last price:
$47.90
Seasonality move :
1.88%
Day range:
$47.63 - $48.41
52-week range:
$37.49 - $56.76
Dividend yield:
1.42%
P/E ratio:
15.44x
P/S ratio:
1.70x
P/B ratio:
3.25x
Volume:
2.8M
Avg. volume:
2.2M
1-year change:
13.26%
Market cap:
$8.3B
Revenue:
$4.8B
EPS (TTM):
$3.10

Analysts' Opinion

  • Consensus Rating
    Genpact Ltd. has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $50.36, Genpact Ltd. has an estimated upside of 5.12% from its current price of $47.91.
  • Price Target Downside
    According to analysts, the lowest downside price target is $42.00 representing 100% downside risk from its current price of $47.91.

Fair Value

  • According to the consensus of 11 analysts, Genpact Ltd. has 5.12% upside to fair value with a price target of $50.36 per share.

G vs. S&P 500

  • Over the past 5 trading days, Genpact Ltd. has overperformed the S&P 500 by 0.17% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Genpact Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Genpact Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Genpact Ltd. reported revenues of $1.3B.

Earnings Growth

  • Genpact Ltd. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Genpact Ltd. reported earnings per share of $0.83.
Enterprise value:
8.9B
EV / Invested capital:
--
Price / LTM sales:
1.70x
EV / EBIT:
11.77x
EV / Revenue:
1.79x
PEG ratio (5yr expected):
0.24x
EV / Free cash flow:
13.93x
Price / Operating cash flow:
13.25x
Enterprise value / EBITDA:
10.60x
Gross Profit (TTM):
$1.8B
Return On Assets:
10.65%
Net Income Margin (TTM):
11.01%
Return On Equity:
22.29%
Return On Invested Capital:
13.73%
Operating Margin:
15.74%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $4.4B $4.7B $5B $1.2B $1.3B
Gross Profit $1.5B $1.6B $1.8B $423M $465M
Operating Income $605.8M $658M $760.2M $179.4M $203.4M
EBITDA $701.5M $744.8M $844M $200.7M $227.2M
Diluted EPS $2.31 $3.64 $3.10 $0.74 $0.83
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $2.1B $1.8B $1.9B $2.4B $2.2B
Total Assets $5B $4.5B $4.6B $5.3B $5.4B
Current Liabilities $1.3B $1.6B $979M $1.3B $1.5B
Total Liabilities $3.1B $2.8B $2.6B $2.9B $2.8B
Total Equity $2B $1.7B $2B $2.4B $2.5B
Total Debt $2B $1.5B $1.4B $1.8B $1.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $528.5M $604.1M $729.4M $228.5M $308.4M
Cash From Investing -$59.4M -$83.6M -$164.9M -$20.3M -$19.2M
Cash From Financing -$438.5M -$52.1M -$833.1M -$109.7M -$209M
Free Cash Flow $472.5M $520.4M $642.3M $208.2M $288.9M
G
Sector
Market Cap
$8.3B
$486.6M
Price % of 52-Week High
84.41%
79.89%
Dividend Yield
1.42%
0%
Shareholder Yield
6.26%
1.54%
1-Year Price Total Return
13.26%
--
Beta (5-Year)
0.756
0.550
Dividend yield:
1.42%
Annualized payout:
$0.61
Payout ratio:
20.53%
Growth streak:
5 years

Technicals

8-day SMA
Buy
Level $47.53
200-day SMA
Buy
Level $44.54
Bollinger Bands (100)
Buy
Level 40.38 - 45.56
Chaikin Money Flow
Buy
Level 81.8M
20-day SMA
Buy
Level $45.97
Relative Strength Index (RSI14)
Buy
Level 70.20
ADX Line
Buy
Level 41.62
Williams %R
Sell
Level -11.5834
50-day SMA
Buy
Level $42.92
MACD (12, 26)
Buy
Level 1.36
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Neutral
Level 224.4M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.7583)
Buy
CA Score (Annual)
Level (0.428)
Buy
Beneish M-Score (Annual)
Level (-2.5074)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.8247)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS). The BCMI segment provides application processing, collections and customer services, equipment and auto loan servicing, mortgage origination and servicing, risk management and compliance services, reporting and monitoring services, wealth management operations support, end-to-end information technology services, application development and maintenance, managed services, financial crimes support, and consulting. The CGRLH segment offers supply chain management, pricing and trade promotion management, order management, digital commerce, customer experience, and risk management. The HMS segment involves industry-specific solutions for the Industrial Internet of Things (IIoT), user experience, order and supply chain management, data engineering, digital content management, and risk management. The company was founded in 1997 by Pramod Bhasin and is headquartered in Hamilton, Bermuda.

Stock Forecast FAQ

In the current month, G has received 4 Buy ratings 7 Hold ratings, and 0 Sell ratings. The G average analyst price target in the past 3 months is $50.36.

  • Where Will Genpact Ltd. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Genpact Ltd. share price will rise to $50.36 per share over the next 12 months.

  • What Do Analysts Say About Genpact Ltd.?

    Analysts are divided on their view about Genpact Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genpact Ltd. is a Sell and believe this share price will drop from its current level to $42.00.

  • What Is Genpact Ltd.'s Price Target?

    The price target for Genpact Ltd. over the next 1-year time period is forecast to be $50.36 according to 11 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.

  • Is G A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Genpact Ltd. is a Hold. 7 of 11 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of G?

    You can purchase shares of Genpact Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genpact Ltd. shares.

  • What Is The Genpact Ltd. Share Price Today?

    Genpact Ltd. was last trading at $47.90 per share. This represents the most recent stock quote for Genpact Ltd.. Yesterday, Genpact Ltd. closed at $47.91 per share.

  • How To Buy Genpact Ltd. Stock Online?

    In order to purchase Genpact Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock